Big Blog

Arts & Culture
Biological Science
Blog Watch
Computer Games
Computer Security
Cricket
Data Privacy
Developer
Domain Names
E-commerce
Gadgets
General Science
Handhelds
IP & Patents
Java
Linux
MP3
Nanotech
Online Auctions
Online Legal Issues
Open Source
Personal Finance
Photography
Quirky
Robotics
Search Engines
Space Science
Top Internet
Top Stories
Top Tech
Video Games
Web Developer
Webmaster Tips
XML & Metadata
{Home}



DataLase and ORBID Settle Patent Infringement Case: related news

DataLase and ORBID Settle Patent Infringement Case

DataLase and ORBID have today agreed to settle the patent infringement case brought by ORBID against DataLase and FractureCode in the Netherlands relating to ORBID's patents on their 2DMI technology. Whilst ORBID will be continuing its case against FractureCode, it will withdraw the case against DataLase. John Mills, Managing Director of DataLase said: "Our co-operation with FractureCode had effectively ceased some months ago, and needless to say the ORBID Corporation lawsuit caught us by surprise. We had no idea that ORBID believes that FractureCode is infringing its patents, and we are happy to reassure ORBID that we will not be working with FractureCode again."

DataLase and ORBID Settle Patent Infringement Case

WIDNES, CHESHIRE, UNITED KINGDOM -- 07/03/08 -- DataLase and ORBID have today agreed to settle the patent infringement case brought by ORBID against DataLase and FractureCode in the Netherlands relating to ORBID's patents on their 2DMI technology. Whilst ORBID will be continuing its case against FractureCode, it will withdraw the case against DataLase. John Mills, Managing Director of DataLase said: "Our co-operation with FractureCode had effectively ceased some months ago, and needless to say the ORBID Corporation lawsuit caught us by surprise. We had no idea that ORBID believes that FractureCode is infringing its patents, and we are happy to reassure ORBID that we will not be working with FractureCode again."

DataLase and ORBID Settle Patent Infringement Case

WIDNES, CHESHIRE, UNITED KINGDOM -- (MARKET WIRE) -- 07/03/08 -- DataLase and ORBID have today agreed to settle the patent infringement case brought by ORBID against DataLase and FractureCode in the Netherlands relating to ORBID's patents on their 2DMI technology. Whilst ORBID will be continuing its case against FractureCode, it will withdraw the case against DataLase. John Mills, Managing Director of DataLase said: "Our co-operation with FractureCode had effectively ceased some months ago, and needless to say the ORBID Corporation lawsuit caught us by surprise. We had no idea that ORBID believes that FractureCode is infringing its patents, and we are happy to reassure ORBID that we will not be working with FractureCode again."

DataLase and ORBID Settle Patent Infringement Case

WIDNES, CHESHIRE, UNITED KINGDOM -- (MARKET WIRE) -- 07/03/08 -- DataLase and ORBID have today agreed to settle the patent infringement case brought by ORBID against DataLase and FractureCode in the Netherlands relating to ORBID's patents on their 2DMI technology. Whilst ORBID will be continuing its case against FractureCode, it will withdraw the case against DataLase. John Mills, Managing Director of DataLase said: "Our co-operation with FractureCode had effectively ceased some months ago, and needless to say the ORBID Corporation lawsuit caught us by surprise. We had no idea that ORBID believes that FractureCode is infringing its patents, and we are happy to reassure ORBID that we will not be working with FractureCode again."

DataLase and ORBID Settle Patent Infringement Case

WIDNES, CHESHIRE, UNITED KINGDOM--(MARKET WIRE)--Jul 3, 2008 -- DataLase and ORBID have today agreed to settle the patent infringement case brought by ORBID against DataLase and FractureCode in the Netherlands relating to ORBID's patents on their 2DMI technology. Whilst ORBID will be continuing its case against FractureCode, it will withdraw the case against DataLase. John Mills, Managing Director of DataLase said: "Our co-operation with FractureCode had effectively ceased some months ago, and needless to say the ORBID Corporation lawsuit caught us by surprise. We had no idea that ORBID believes that FractureCode is infringing its patents, and we are happy to reassure ORBID that we will not be working with FractureCode again."

ORBID Corporation and DataLase Settle Patent Infringement Case

ORBID Corporation, Inc., a leading provider of fingerprint/Unique Identity (UID) solutions for cost-effectively and securely guaranteeing the authenticity and integrity of products, today announced they have reached a settlement agreement with DataLase, Ltd. related to patents on ORBID's 2DMI technology. As a result, ORBID is withdrawing its case against DataLase, while continuing to pursue the case against FractureCode, a division of Filtrona PLC.

AMS, ADESA and Live Global Bid Settle the Patent Infringement Case Relating to the AMS Patent

CARMEL, Ind., BUSINESS WIRE -- Auction Management Solutions, Inc. ("AMS"), ADESA and Live Global Bid, Inc. jointly announce that they have settled the patent infringement case relating to AMS' U.S. Patent No. 6,813,612 ("the '612 patent"). Live Global Bid recently was acquired by ADESA and is now named "LiveBlock Auctions International" or "LAI".

AMS, ADESA and Live Global Bid Settle the Patent Infringement Case Relating to the AMS Patent

CARMEL, Ind., BUSINESS WIRE -- Auction Management Solutions, Inc. ("AMS"), ADESA and Live Global Bid, Inc. jointly announce that they have settled the patent infringement case relating to AMS' U.S. Patent No. 6,813,612 ("the '612 patent"). Live Global Bid recently was acquired by ADESA and is now named "LiveBlock Auctions International" or "LAI".

AMS, ADESA and Live Global Bid Settle the Patent Infringement Case Relating to the AMS Patent

CARMEL, Ind. (Business Wire) -- Auction Management Solutions, Inc. ("AMS"), ADESA and Live Global Bid, Inc. jointly announce that they have settled the patent infringement case relating to AMS' U.S. Patent No. 6,813,612 ("the '612 patent"). Live Global Bid recently was acquired by ADESA and is now named "LiveBlock Auctions International" or "LAI".

AMS, ADESA and Live Global Bid Settle the Patent Infringement Case Relating to the AMS Patent

CARMEL, Ind., Aug 15, 2008 (BUSINESS WIRE) -- Auction Management Solutions, Inc. ("AMS"), ADESA and Live Global Bid, Inc. jointly announce that they have settled the patent infringement case relating to AMS' U.S. Patent No. 6,813,612 ("the '612 patent"). Live Global Bid recently was acquired by ADESA and is now named "LiveBlock Auctions International" or "LAI".

AMS, ADESA and Live Global Bid Settle the Patent Infringement Case Relating to the AMS Patent

ADESA and Live Global Bid, Inc. jointly announce that they have settled the patent infringement case relating to AMS

AMS, ADESA and Live Global Bid Settle the Patent Infringement Case Relating to the AMS Patent

ADESA and Live Global Bid, Inc. jointly announce that they have settled the patent infringement case relating to AMS

AMS, ADESA and Live Global Bid Settle the Patent Infringement Case Relating to the AMS Patent

ADESA and Live Global Bid, Inc. jointly announce that they have settled the patent infringement case relating to AMS

DP6946 Patent Thickets and the Market for Innovation: Evidence from Settlement of Patent Disputes

We study how fragmentation of patent rights (‘patent thickets’) and the formation of the Court of Appeal for the Federal Circuit (CAFC) affected the duration of patent disputes, and thus the speed of technology diffusion through licensing. We develop a model of patent litigation which predicts faster settlement agreements when patent rights are fragmented and when there is less uncertainty about court outcomes, as was associated with the ‘pro-patent shift’ of CAFC. The model also predicts that the impact of fragmentation on settlement duration should be smaller under CAFC. We confirm these predictions empirically using a dataset that covers nearly all patent suits in U.S. federal district courts during the period 1975-2000. Finally, we analyze how fragmentation affects total settlement delay, taking into account both reduction in duration

Google Sued For Patent Infringement For Keeping Track Of How Many Ads People Click On

It still seems rather amusing (if not twisted) that some patent system supporters are trying to convince the world Google would be harmed by an absence of software patents. Instead, it seems increasingly obvious that it would only serve to help Google, who is a regular target of questionable patent infringement lawsuits. Take the latest such case as an example. A company by the name of Web Tracking Solutions, which ironically enough, doesn't appear to have much of a web presence (if any), has sued Google for patent infringement, claiming that its patent on third-party on-line accounting systems is being violated by Google's AdSense offering.

Veoh Court Victory May Be Bad Sign for Viacom - YouTube infringement case may have gotten weaker

Google is in the midst of a $1 billion copyright infringement lawsuit filed by Viacom for YouTube violations of copyright infringement. Google hopes that a recent ruling in the favor of video site Veoh will mean good things for the YouTube case. In both the Veoh case (filed by porn company Io after the company’s adult films were found on the Veoh site) and the YouTube case, the defendants’ believe that they are not responsible for hosting liabilities because of a “safe harbor” clause in the Digital Millennium Copyright Act. These sites are simply service providers that have to do minimal things to make sure that copyright isn’t violated. The court has ruled that this is true in the case of Veoh. Google believes this helps its case against Viacom but Viacom says that there are enough differences between YouTube and Veoh that it will contin

German Court Rules Qualcomm GSM Patent Claim Against Nokia Invalid

The German Federal Patent Court ruled today that Qualcomm’s GSM patent case against Nokia (NYSE: NOK) is invalid, Reuters reports. This is the third court to conclude that the American chipmaker’s patent claims against Nokia are “without merit,” said the Finnish handset maker. The United Kingdom High Court, and the U.S. International Trade Commission have also ruled that Qualcomm’s GSM patent claims against Nokia to be invalid. The two will meet again in German court in October, when a second Qualcomm (NSDQ: QCOM) patent case will be heard. The news comes on the same day that Qualcomm and Nokia are to meet in a Deleware Court over its ongoing patent dispute.

Supreme Court strengthens patent exhaustion doctrine

The United States Supreme Court has unanimously held in Quanta Computer, Inc. v. LG Electronics, Inc. that the patent law cannot be used to control the subsequent use or disposition of a product "that substantially embodies a patent" once the product has been sold with authority of the patent owner. "The authorized sale of an article that substantially embodies a patent exhausts the patent holder's rights and prevents the patent holder from invoking the patent law to control post-sale use of the article." Patent exhaustion applies whether the patents are directed to products or methods. "Our precedents do not differentiate transactions involving embodiments of patented methods or processes from those involving patented apparatuses or materials.

Drugs industry protecting 'morally unacceptable' patent system

Add our medical news to digg - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to NewsVine - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Fark - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Furl - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Shadows - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to YahooMyWeb - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Reddit -Drugs industry protecting 'morally unacceptable' patent system Add our medical news to StumbleUpon - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Facebook - Drugs industry protecting 'morally unaccep

DataLase, ORBID agree to settle patent infringement case

Industrial Lasers Solutions is a leading international resource for technology information on industrial laser materials processing.

EV Group Files Patent Infringement Lawsuit Against the 3M Company

EV Group (EVG), a leading supplier of wafer-bonding and lithography equipment for the advanced semiconductor and packaging, MEMS, silicon-on-insulator (SOI) and emerging nanotechnology markets, today announced that it has filed a patent infringement lawsuit in federal court of New York against the 3M Company ("3M"). The complaint alleges that 3M has infringed upon a U.S. Patent through the marketing and sale of the 3M Wafer Support System, which is used in the production of silicon wafers. The complaint seeks damages to compensate EVG for 3M's wrongful infringement and an injunction against 3M from all future infringement of the Patent.

EV Group Files Patent Infringement Lawsuit Against the 3M Company

ST. FLORIAN, Austria, July 14 /PRNewswire/ -- EV Group (EVG), a leading supplier of wafer-bonding and lithography equipment for the advanced semiconductor and packaging, MEMS, silicon-on-insulator (SOI) and emerging nanotechnology markets, today announced that it has filed a patent infringement lawsuit in federal court of New York against the 3M Company ("3M"). The complaint alleges that 3M has infringed upon a U.S. Patent through the marketing and sale of the 3M Wafer Support System, which is used in the production of silicon wafers. The complaint seeks damages to compensate EVG for 3M's wrongful infringement and an injunction against 3M from all future infringement of the Patent.

EV Group Files Patent Infringement Lawsuit Against the 3M Company

ST. FLORIAN, Austria, July 14 /PRNewswire/ -- EV Group (EVG), a leading supplier of wafer-bonding and lithography equipment for the advanced semiconductor and packaging, MEMS, silicon-on-insulator (SOI) and emerging nanotechnology markets, today announced that it has filed a patent infringement lawsuit in federal court of New York against the 3M Company ("3M"). The complaint alleges that 3M has infringed upon a U.S. Patent through the marketing and sale of the 3M Wafer Support System, which is used in the production of silicon wafers. The complaint seeks damages to compensate EVG for 3M's wrongful infringement and an injunction against 3M from all future infringement of the Patent.

EV Group Files Patent Infringement Lawsuit Against the 3M Company

ST. FLORIAN, Austria, July 14 /PRNewswire/ -- EV Group (EVG), a leading supplier of wafer-bonding and lithography equipment for the advanced semiconductor and packaging, MEMS, silicon-on-insulator (SOI) and emerging nanotechnology markets, today announced that it has filed a patent infringement lawsuit in federal court of New York against the 3M Company ("3M"). The complaint alleges that 3M has infringed upon a U.S. Patent through the marketing and sale of the 3M Wafer Support System, which is used in the production of silicon wafers. The complaint seeks damages to compensate EVG for 3M's wrongful infringement and an injunction against 3M from all future infringement of the Patent.

MIT sues Affymetrix for patent infringement

Affymetrix, the Santa Clara maker of tools used to study DNA and diagnose diseases, was sued for patent infringement by the Massachusetts Institute of Technology over the company's GeneChip system used to analyze genes. Affymetrix has knowingly infringed the patent, MIT and a company started by an MIT professor said in a federal court complaint filed Tuesday in Boston. Affymetrix filed an application with the U.S. Patent and Trademark Office in September 2004, six months after a similar patent was approved for MIT, the university said in its complaint. The patent regulators ruled in May 2007 that the MIT group was the first inventor, according to the complaint. The GeneChip technology is used to develop new therapeutic drugs and to investigate the cause of cancer, AIDS and other diseases, Affymetrix has said.


Search News:


Copyright © 2001-2008 Jonathan Hedley